Invesaro

Stocks Health care HIND

NASDAQ · Health care

Vyome Holdings, Inc (HIND)

Vyome Holdings, Inc brought in -$2M of revenue over the twelve months to June 30, 2026, down 130.6% from a year earlier. It posted a net loss of $11.3M. At June 30, 2026 it held $7.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Free, no password. An email when HIND files with the SEC.

Price
$1.55
+0.65% on the day · November 11, 2026
52-week range $1.53 to $5.88
Market cap
$10.9M
Revenue (last 12 months)
-$2M
-130.6% year on year

Key facts about Vyome Holdings, Inc

Net worth
Vyome Holdings, Inc has a market value (market cap) of $10.9M at the latest share price, and shareholders' equity of $7.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $319.7K (-96.0% year on year), with a net loss of $10.3M. Over the 12 months to June 30, 2026: revenue -$2M, net loss $11.3M.
Cash flow
In fiscal 2025 operations used $3.7M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Vyome Holdings, Inc's next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Vyome Holdings, Inc does

Vyome Holdings, Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker HIND.

Revenue and profit by year

Revenue
FY18: $9.1M $9.1M FY18FY19: $3.3M $3.3M FY19FY20: $11.3M $11.3M FY20FY21: $13.6M $13.6M FY21FY22: $11.2M $11.2M FY22FY23: $8.7M $8.7M FY23FY24: $8M $8M FY24FY25: $319.7K $319.7K FY25
Net income
FY18: -$37.4M -$37.4M FY18FY19: -$23.7M -$23.7M FY19FY20: -$21.6M -$21.6M FY20FY21: -$63.1M -$63.1M FY21FY22: -$46.2M -$46.2M FY22FY23: -$11.4M -$11.4M FY23FY24: -$1.4M -$1.4M FY24FY25: -$10.3M -$10.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$319.7K-$10.5M-$10.3M-$4.86n/a
2024$8M-$1M-$1.4M-$6,001.39n/a
2023$8.7M-$15.4M-$11.4M-$48,110.93-$17M
2022$11.2M-$46.4M-$46.2M-$2,743,078.46-$22M
2021$13.6M-$57.9M-$63.1M-$7,278,855.68-$15.7M
2020$11.3M-$12.5M-$21.6M-$8,064,972.09-$8.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around January 12, 2027.

Estimated from its filing rhythm: about 140 days after its last report of August 25, 2026, its usual gap. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where HIND ranks in Health care

Revenue$319.7K
#694 of 751 in Health care · Bottom 8%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Vyome Holdings, Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 28, 2026
  2. August 25, 2026
  3. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 98% to $27K versus the same quarter last year; diluted EPS -$0.10 versus -$799.90.
  4. May 29, 2026
  5. May 12, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue fell 97% to $31.6K versus the same quarter last year; diluted EPS -$0.15 versus -$761.59.
  6. April 29, 2026
  7. March 31, 2026
  8. March 20, 2026
  9. March 18, 2026
    Annual report 10-K · period to December 31, 2025Revenue fell 96% to $319.7K versus the prior year; diluted EPS -$4.86 versus -$6,001.39.
  10. February 25, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 3, 2026. Insider transactions on SEC

Insider trades

What the people running Vyome Holdings, Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HIND

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Bigger Michael13G, passive with 6 related filers 9.68% 320,000 February 21, 2025
FirstFire Global Opportunities Fund LLC13G, passive 6.1% 200,000 February 24, 2025
Leonite Fund I, LP13G, passive with 1 related filers 6.1% 200,000 February 24, 2025

Latest filings below 5%: CVI Investments, Inc. 0% (August 14, 2025); L1 Capital Global Opportunities Master Fund, Ltd. 0.33% (August 14, 2025); Ayrton Capital LLC 0% (August 13, 2025); Dominion Capital LLC 0.76% (April 4, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 454,456 shares in total, about $704.4K at the last price.

HolderSharesAs of
Jolly MohanjitDirector 454,456454,456 held indirectly August 15, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HIND

What does Vyome Holdings, Inc do?

Vyome Holdings, Inc is a company in the Health care sector, listed on NASDAQ as HIND. Its shares trade on NASDAQ under the ticker HIND.

What is Vyome Holdings, Inc's net worth?

Vyome Holdings, Inc has a market value (market cap) of $10.9M at the latest share price, and shareholders' equity of $7.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Vyome Holdings, Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $11.3M.

How much revenue does Vyome Holdings, Inc make?

Over the twelve months to June 30, 2026 Vyome Holdings, Inc reported revenue of -$2M. That is 130.6% less than a year earlier.

When did Vyome Holdings, Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 3, 2026.

When is Vyome Holdings, Inc's next earnings report?

Vyome Holdings, Inc's next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare HIND with

Compare HIND with any company

Follow HIND

Get an email when Vyome Holdings, Inc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when HIND files with the SEC.

Where the numbers come from

Financial figures are the values Vyome Holdings, Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.